Osteoarthritis (OA) is one of the most common forms of arthritis, affecting millions worldwide. It is a degenerative joint disease characterised by the breakdown of cartilage, leading to pain, stiffness, and reduced mobility. Traditional treatments such as physical therapy, anti-inflammatory medications, and, in severe cases, surgery, have provided varying degrees of relief – however, a new therapy called NStride is emerging as a promising alternative for managing osteoarthritis.
What is NStride?
NStride, or Autologous Protein Solution (APS) therapy, is a cutting-edge treatment designed to harness the body’s natural healing processes to combat inflammation and cartilage degradation associated with mild to moderate osteoarthritis. This therapy involves extracting and concentrating anti-inflammatory proteins and growth factors from a patient’s own blood to target the affected joint.
How Does NStride Work?
The NStride process begins with a small blood draw from the patient. The blood is then processed using a specialised centrifuge system to isolate plasma rich in anti-inflammatory cytokines and growth factors. This concentrated solution is subsequently injected directly into the arthritic joint.
The therapeutic proteins in the NStride injection work by reducing inflammation and promoting the repair of damaged cartilage. The solution specifically targets the underlying biological processes that drive osteoarthritis, offering a more targeted and potentially longer-lasting relief compared to conventional treatments.
Benefits of NStride Therapy
Non-Surgical Solution:
NStride offers a minimally invasive alternative to surgery, which can be particularly appealing for patients looking to avoid the risks and downtime associated with surgical procedures.
Reduction in Pain and Inflammation:
Studies have shown that NStride can significantly reduce pain and inflammation in patients with osteoarthritis. The anti-inflammatory proteins help to mitigate the body’s inflammatory response, which is a primary contributor to the symptoms of osteoarthritis.
Improved Joint Function:
By addressing both inflammation and cartilage health, NStride therapy can lead to improved joint function, enabling patients to return to their daily activities with greater ease and comfort.
Personalised Treatment:
Since NStride uses the patient’s own blood, the therapy is inherently personalised, reducing the risk of allergic reactions or adverse side effects.
Evidence and Clinical Trials
Clinical trials and studies have demonstrated the effectiveness of NStride in treating osteoarthritis, with many patients reporting a noticeable reduction in pain and an improvement in joint function within weeks of receiving the injection. Furthermore, the benefits of NStride therapy can last for a year or more, offering a significant advantage over traditional corticosteroid injections, which typically provide only short-term relief.
NStride represents a significant advancement in the treatment of osteoarthritis, providing a non-surgical, personalised approach to managing this chronic condition. By leveraging the body’s natural healing processes, NStride offers hope for long-term relief from the debilitating symptoms of osteoarthritis, improving the quality of life for many patients.
Private Injection Clinics offer Ultrasound-Guided NStride Injections – For more information and pricing please take a visit the website.
Private Injection Clinics are based on the coast in Leigh on Sea and in Colchester, Essex – perfect for patients in Essex, Kent, London, and surrounding areas.